MedTrace Logo

Introduction and Influence of Total Mesorectal Excision (TME) in the Treatment of Rectal Cancer

NCT00910143 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 194

Last updated 2009-05-29

No results posted yet for this study

Summary

Total mesorectal excision (TME) is a rather new operation technique in the treatment of rectal cancer. It is known to reduce the rate of local recurrences. However, the influence on long-term survival is unclear.

Conditions

Interventions

PROCEDURE

conventional rectal surgery

type of rectal surgery before the introduction of TME

PROCEDURE

total mesorectal excision

total mesorectal excision

Sponsors & Collaborators

  • Insel Gruppe AG, University Hospital Bern

    lead OTHER

Principal Investigators

  • Pietro Renzulli, MD · Bern University Hospital, 3010 Bern, Switzerland

Eligibility

Min Age
16 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
1993-01-31
Primary Completion
2001-12-31
Completion
2001-12-31

Countries

  • Switzerland

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00910143 on ClinicalTrials.gov